Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells

International Journal of Cancer

Volumn 74, Issue 1, 1997, Pages 69-74

  Young, M Rita I ^a,b   Wright, Mark A ^a   Lozano, Yvonne ^a   Prechel, M Margaret ^b   Benefield, Janet ^a,b   Leonetti, John P ^b   Collins, Sharon L ^b   Petruzzelli, Guy J ^b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SUPPRESSOR CELL;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECURRENCE; SURVIVAL RATE; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030979282     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D     Document Type: Article

References (35)

1. ANGULO, I., RORDRIGUEZ, R., GARCIA, B., MEDINA, M., NAVARRO, J. and SUBIZA, J. L., Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-γ. J. Immunol., 155, 15-26 (1945).
2. ANTHONY, P.P. and RAMANI, P., Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand fator and Ulex europaeus agglutinin 1. J. clin. Pathol., 44, 29-32 (1991).
3. BERARDI, A.C., WANG, A., LEVINE, J.D., LOPEZ, P. and SCADDEN, D.T., Functional isolation and characterization of human hematopoietic stem cells. Science, 267, 104-108 (1995).
4. BERDEL, W.E., DANHAUSER-RIEDL, S., OBERBERG, D. and ZAFFERANI, M., Effects of hematopoietic growth factors on malignant nonhematopoietic cells. Seminars Oncol. 19, 41-45 (1992).
5. CHAKRABORTY, N.G., ERGIN, M.T. and MUKHERJI, B., Suppressor function of lymphocytes activated in in vitro co-culture against autologous tumor cells and expanded in interleukin-2. In Vivo, 5, 631-635 (1991).
6. CHIKAMATSU, K., EURA, M., NAKANO, K., MASUYAMA, K. and ISHIKAWA, T., Functional and T cell receptor gene usage analysis of cytotoxic T lymphocytes in fresh tumor-infiltrating lymphocytes from human head and neck cancer. Japn. J. Cancer Res., 86, 477-483 (1995).
7. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R.C., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
8. FIELD, E.H. and BECKER, G.C., Blocking of mixed lymphocyte reaction by spleen cells from total lymphoid-irradiated mice involves interruption of the IL-2 pathway. J. Immunol., 148, 354-359 (1992).
9. GASPARINI, G., WEIDNER, N., MALUTA, S., POZZA, F., BORACCHI, P., MEZZETTI, M., TESTOLIN, A. and BEVILACQUA, P., Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int. J. Cancer, 55, 739-744 (1993).
10. GOODING, R., RICHES, P., DADIAN, G., MOORE, J. and GORE, M., Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2. Brit. J. Cancer, 72, 452-455 (1995).
11. HADDEN, J.W., ENDICOTT, J., BAEKEY, P., SKIPPER, P. and HADDEN, E.M., Interleukins and contrasuppression induce immune regression of head and neck cancer. Arch. Otolaryngol. Head Neck Surg., 120, 395-403 (1994).
12. KAFFENBERGER, W., HOLZER-MÜLLER, L., AUBERGER, T., CLASEN, B.P., HOHLMEIER, G. and VAN BEUNINGEN, D., An immunological outcome predictive score for head and neck carcinoma patients. Strahlentherapie Onkol., 171, 444-453 (1995).
13. LANG, S.H., MILLER, W.R., DUNCAN, W. and HABIB, F.K., Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int. J. Cancer, 59, 235-241 (1994).
14. LETESSIER, E.M., SACCHI, M., JOHNSON, J.T., HERBERMAN, R.B. and WHITESIDE, T.L., The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer. Cell. Immunol., 130, 446-458 (1990).
15. MANN, E.A., SPIRO, J.D., CHEN, L.L. and KREUTZER, D.L., Cytokine expression by head and neck squamous cell carcinomas. Amer. J. Surg., 164, 567-573 (1992).
16. MATTIJSSEN, V., PETERS, H.M., SCHALKWIJK, L., MANNI, J.J., VAN'T HOFGROOTENBOER, B., DE MULDER, P.H. and RUITER, D.J., E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int. J. Cancer, 55, 580-585 (1993).
17. MOORE, S.C., THEUS, S.A., BARNETT, J.B. and SODERBERG, L.S., Cytokine regulation of bone marrow natural suppressor cell activity in the suppression of lymphocyte function. Cell. Immunol., 141, 398-408 (1992).
18. O'MAHONY, A.M., O'SULLIVAN, G.C., O'CONNELL, J., COTTER, T.G. and COLLINS, J.K., An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J. Immunol., 151, 4847-4856 (1993).
19. 2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF. J. Leukocyte Biol. 53, 86-92 (1993).
20. PAVEL, P., HALAPI, E., PISA, E.K., GERDIN, E., HISING, C., BUCHT, A., GERDIN, B. and KIESSLING, R., Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. nat. Acad. Sci. (Wash.), 89, 7708-7712 (1992).
21. 3 treatments to block induction of immune suppressive granulocyte-macrophage progenitor cells. Cancer Immunol. Immunother., 42, 213-220 (1996).
22. RABINOWICH, H., VITOLO, D., ALTARAC, S., HERBERMAN, R.B. and WHITESIDE, T.L., Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. J. Immunol., 149, 340-349 (1992).
23. SCHMIDT-PAK, A., IP, G., WRIGHT, M.A. and YOUNG, M.R.I., Treating tumor-bearing mice with low dose interferon-γ plus tumor necrosis factor-α to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to IL-2 immunotherapy. Cancer Res., 55, 885-890 (1995).
24. SCHMIDT-WOLF, I.G., DEJBAKHSH-JONES, S., GINZTON, N., GREENBERG, P. and STROBER, S., T-cell subsets and suppressor cells in human bone marrow. Blood, 80, 3242-3250 (1992).
25. 2 production in fresh tissues of head and neck cancer patients. Head Neck, 17, 108-113 (1995).
26. WANEBO, H.J., BLACKINTON, D., KOUTTAB, N. and MEHTA, S., Contribution of serum inhibitory factors and immune cellular detects to the depressed cell-mediated immunity in patients with head and neck cancer. Amer. J. Surg., 166, 389-394 (1993).
27. WANEBO, H.J., RILEY, T., KARZ, D., PACE, R.C., JOHNS, M.E. and CANTRELL, R.W., Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell. Cancer, 61, 462-474 (1988).
28. + activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy. Int. J. Cancer. 61, 470-474 (1995).
29. 3 plus γ-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells. Cancer Res., 53, 6006-6010 (1993).
30. 3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cells. Cancer Lett., 104, 153-161 (1996a).
31. + cells in cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin. Cancer Res., 1, 95-103 (1995).
32. YOUNG, M.R.I. and WRIGHT, M.A., Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce immune suppressor and tumor growth-promoting activities of bone marrow cells, and diminish tumor recurrence and metastasis. Cancer Res., 52, 6335-6340 (1992).
33. YOUNG, M.R.I., WRIGHT, M.A., LOZANO, Y., MATTHEWS, J.P., BENEFIELD, J. and PRECHEL, M.M., Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int. J. Cancer, (1996b), in press.
34. YOUNG, M.R.I., WRIGHT, M.A., MATTHEWS, J.P., MALIK, I. and PRECHEL, M., Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide. J. Immunol., 156, 1916-1922 (1996c).
35. YOUNG, M.R.I., WRIGHT, M.A. and YOUNG, M.E., Antibodies to colony-stimulating factors block Lewis lung carcinoma cell-stimulation of immune suppressive bone marrow cells. Cancer Immunol. Immunother., 33, 146-152 (1991).